A recent study suggests that using artificial intelligence to measure tumor size could reduce treatment failures by more than 70%.

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...

Discover how AI in life sciences enhances disease diagnosis, enabling faster, more accurate detection and improving patient ...

Rice statistician Erzsébet Merényi is part of a team of researchers awarded $1 million by the Cancer Prevention and Research Institute of Texas to develop AI tools that can identify lethal forms of ...

Erzsébet Merényi, a statistics research professor at Rice University, and co-investigators at The University of Texas MD Anderson Cancer Center Pratip Bhattacharya, professor of cancer systems imaging ...

A groundbreaking treatment for prostate cancer now available in Virginia aims to improve patient outcomes while minimizing side effects associated with traditional surgeries and radiation therapies.

“Our prostate cancer drug, for example, being as little as $50 a year treatment compared to $100,000 a year. Yes, it’s a game changer.” The use of AI is not only saving money, but also tim ...

Feb. 3, 2025 — The incidence of advanced prostate cancer in California rose markedly in the decade since doctors stopped routinely screening all men for the disease, according to a new ...

First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone ...

Pathos AI, ( a clinical-stage biotechnology company focused on re-engineering drug development through artificial intelligence, announced the first patient has been dosed in the Company’s Phase 1b/2a ...